Nanosonics Addresses ASX Query on Unusual Trading Activity

Nanosonics Limited ( (AU:NAN) ) has provided an update.

Nanosonics Limited responded to a query from the Australian Securities Exchange (ASX) regarding unusual trading activity in its securities. The company stated that it is not aware of any undisclosed information that could explain the recent price and volume changes and confirmed compliance with ASX Listing Rules, particularly Rule 3.1, which pertains to continuous disclosure obligations.

The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is a company operating in the medical technology industry, primarily focused on infection prevention solutions. The company’s flagship product is the trophon® EPR, a device for high-level disinfection of ultrasound probes, which positions it as a leader in the healthcare market for infection control.

Average Trading Volume: 1,080,725

Technical Sentiment Signal: Buy

Current Market Cap: A$1.47B

For an in-depth examination of NAN stock, go to TipRanks’ Stock Analysis page.